$SYM

KANE CHARLES sold $86K of SYM

KANE CHARLES sold 2,000 shares of Symbotic Inc. (SYM) at $43.21 on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KANE CHARLES
Published Aug 5, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYM
Neutral
high confidence
Mentioned
$SYM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYMNeutralLow
01

Why it matters

The disclosed event is an open-market sale of 2,000 shares at $43.21, totaling $86,420, executed under a pre-arranged Rule 10b5-1 plan. The text contains no additional company developments.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 framing and lack of new fundamentals make it low-impact for trading decisions.

03

What to watch

The article provides only the sale details; it does not state whether the director’s overall position is changing materially over time, nor does it include any company-specific news that could contextualize the sale.

Relevance 2/10Novelty 2/10Timing: filed 2026-08-05 after-hours; transaction dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Symbotic Inc., reported by director Kane Charles.

Company-level read

Ticker impact

$SYMNeutralHigh confidence
Context

Director Kane Charles filed a Form 4 showing an open-market sale of 2,000 Symbotic shares at $43.21 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely sentiment-only and should fade unless accompanied by other disclosures.

Evidence & confidence

The filing is an insider transaction (not a buy), explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory catalyst in the text.

Market effects

No sector read-through provided; insider sale does not change Symbotic’s competitive or demand outlook in the article.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with perceived valuation risk, so traders may watch for follow-on sales or buys in subsequent filings.

Key entities

  • Symbotic Inc.

    Subject of the Form 4 insider transaction disclosure (SYM).

  • Kane Charles

    Director who reported the sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYMHigh

A sorter steers goods in any direction, replacing traditional conveyor systems

Symbotic Inc. (SYM) acquired cellumation GmbH, a German automation company, for its celluveyor technology. The celluveyor is a software-driven sortation platform that replaces traditional conveyors, offering greater density, throughput, and efficiency. Symbotic aims to integrate the technology into its systems and expand its European presence. cellumation will continue operating independently, serving its global customer base.

$SYMMed

Symbotic director Charles Kane sells $78,000 of Class A stock

Symbotic Inc. director Charles Kane sold 2,000 shares of Class A stock for $78,000 at $39 per share on September 1, 2026. The stock currently trades at $41.60, down 30% year-to-date. Symbotic reported Q3 revenue of $721 million, up 22% YoY, and adjusted EBITDA of $95 million, more than double the previous year. Despite strong results, the stock declined in after-hours trading due to concerns over future margins and outlook.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$SYMMed

What’s Really Behind Symbotic’s (SYM) Big Quarter?

Symbotic Inc. (NASDAQ:SYM) reported fiscal Q3 revenue of $721M, up 22% year over year, with net income of $55M versus a $21M loss a year earlier. Adjusted EBITDA rose to $95M. The company said 11 new deployments brought totals to 77 in deployment. Shares face a high forward P/E (238.1) and 28.1% short interest.